This advert is not available!
Lund University was founded in 1666 and is repeatedly ranked among the world’s top universities. The University has around 47 000 students and more than 8 800 staff based in Lund, Helsingborg and Malmö. We are united in our efforts to understand, explain and improve our world and the human condition.
Lund University welcomes applicants with diverse backgrounds and experiences. We regard gender equality and diversity as a strength and an asset.
Description of the workplace
At the Division of Clinical Genetics, Department of Laboratory Medicine, we are looking for an Associate Researcher to work on a project aimed at understanding how blood cancer cells interact with the immune system. A particular goal is to use antibodies directed against blood cancer cells or immunological cells to identify new treatment strategies. The research group is led by Professor Thoas Fioretos and includes about 10 members with expertise in advanced flow cytometry, single-cell analysis, bioinformatics, antibody technology, and experimental in vitro and in vivo studies. The research group is international, works interdisciplinary, and collaborates with several other research groups, healthcare, and the life science industry. We are now seeking an experienced researcher with the ability to work both independently and team-based within the outlined project. As a workplace, we safeguard a positive work environment with respect and consideration in our relations with one another. Read more about our research here.
What we offer
Lund University is a public authority which means that employees get particular benefits, generous annual leave and an advantageous occupational pension scheme. We also have a flexitime agreement that provides good conditions for work/life balance. Read more on the University website about being a Lund University employee Work at Lund University
Work duties
Work duties include advanced in vitro and in vivo studies of blood cancer cells and their interaction with different immunological cells. The work involves FACS analyses, in vitro and in vivo analyses of blood cancer cells and their interaction with immunological cells, as well as the development and evaluation of the treatment effects of different antibodies. It may also be relevant to study other types of cancer that use similar mechanisms as blood cancer cells to evade the immune system. You will also publish articles in scientific journals, contribute to conferences, and be active in various collaborative projects with other research groups, healthcare, and actors within the life science industry. The work within the research group is team-based to achieve success in ongoing projects.
Qualifications
Requirements for employment are:
Additional qualifications for the position are:
Scientific skill is the main employment criterion. During the evaluation, research profile, experience and knowledge will be taken into account. Great emphasis will also be placed on personal suitability. The duties require that you can work well in a group.
Further information
The employment is a permanent, fulltime position (100%) starting July 1st, 2024, or as soon as possible according to agreement. A probationary period of 6 months may be applied.
How to apply
You apply for the position via the University’s recruitment system. The application is to include a CV with a list of publications, a personal letter describing how you meet the qualification requirements and why you are interested in the position, and a copy of the PhD diploma and other documents you wish to highlight.
The university applies individual salary setting. Please state salary claims in your application.
Type of employment | Permanent position |
---|---|
Contract type | Full time |
First day of employment | July 1st, 2024, or according to agreement |
Salary | Monthly salary |
Number of positions | 1 |
Full-time equivalent | 100 |
City | Lund |
County | Skåne län |
Country | Sweden |
Reference number | PA2024/2001 |
Contact |
|
Published | 04.Jun.2024 |
Last application date | 18.Jun.2024 11:59 PM CEST |